Abstract
Introduction: Door-to-CT scan time (DCT) and door-to-needle time (DNT) are important process measures in acute ischemic stroke (AIS) patients undergoing intravenous thrombolysis (IVT). We examined the impact of a telemedical prenotification by emergency medical service (EMS) (called the “Stroke Angel” program) on DCT and DNT and IVT rate compared to standard of care. Patients and Methods: Two prospective observational studies including AIS patients admitted via EMS from 2011 to 2013 (cohort I; n = 496) and from January 1, 2015 to May 31, 2018 (cohort II; n = 349) were conducted. After cohort I, the 4-Item Stroke Scale and a digital thrombolysis protocol were added. Multivariable logistic and linear regression analysis was performed. Results: In cohort I, DCT was lower in the intervention group (13 vs. 26 min using standard of care; p < 0.001), but no significant difference in median DNT (35 vs. 39 min; p = 0.24) was observed. In cohort II, a reduction of DCT (8 vs. 15 min; p < 0.001) and DNT (25 vs. 29 min p = 0.003) was observed in the intervention group. Compared to standard of care, the likelihood of DCT ≤10 min or DNT ≤20 min in the intervention group was 2.7 (adjusted odds ratio [aOR] 2.7; 95% CI: 2.1–3.5) and 1.8 (aOR 1.8; 95% CI: 1.1–2.9), respectively. In cohort II, IVT rate was higher (aOR 1.4; 95% CI: 1.1–1.9) in the intervention group. Conclusion: Although the positive effects of Stroke Angel in AIS provided a rationale for implementation in routine care, larger studies of practice implementation will be needed. Using Stroke Angel in the prehospital management of AIS impacts on important process measures of IVT delivery.
Journal Section:
Editor's choice
References
1.
Zerna
C
, Thomalla
G
, Campbell
BCV
, Rha
J-H
, Hill
MD
. Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke
. Lancet
. 2018
;392
(10154
):1247
–56
.2.
Man
S
, Xian
Y
, Holmes
DN
, Matsouaka
RA
, Saver
JL
, Smith
EE
, . Association between thrombolytic door-to-needle time and 1-Year mortality and readmission in patients with acute ischemic stroke
. JAMA
. 2020
;323
(21
):2170
–84
.3.
Powers
WJ
, Rabinstein
AA
, Ackerson
T
, Adeoye
OM
, Bambakidis
NC
, Becker
K
, . Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
. Stroke
. 2019
;50
(12
):e344
–418
.4.
Kobayashi
A
, Czlonkowska
A
, Ford
GA
, Fonseca
AC
, Luijckx
GJ
, Korv
J
, . European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre-hospital management of stroke
. Eur J Neurol
. 2018
;25
(3
):425
–33
.5.
Ringleb
P
, Hamann
G
, Röther
J
, Jansen
O
, Groden
C
, Veltkamp
R
. Akuttherapie des ischämischen Schlaganfalls - Rekanalisierende Therapie
. Akt Neurol
. 2016
;43
(2
):82
–91
.6.
Ragoschke-Schumm
A
, Walter
S
, Haass
A
, Balucani
C
, Lesmeister
M
, Nasreldein
A
, . Translation of the ‘time is brain’ concept into clinical practice: focus on prehospital stroke management
. Internat. J. Stroke
. 2014
;9
(3
):333
–40
.7.
Huang
Q
, Zhang
JZ
, Xu
WD
, Wu
J
. Generalization of the right acute stroke promotive strategies in reducing delays of intravenous thrombolysis for acute ischemic stroke: a meta-analysis
. Medicine
. 2018
;97
(25
):e11205
.8.
Price
C
, Shaw
L
, Islam
S
, Javanbakht
M
, Watkins
A
, McMeekin
P
, . Effect of an enhanced paramedic acute stroke treatment assessment on thrombolysis delivery during emergency stroke care. A cluster randomized clinical trial
. JAMA Neurol
. 2020
:e200611
.9.
Winburn
AS
, Brixey
JJ
, Langabeer
J
, Champagne-Langabeer
T
. A systematic review of prehospital telehealth utilization
. J Telemed Telecare
. 2018
;24
(7
):473
–81
.10.
Yaeger
KA
, Shoirah
H
, Kellner
CP
, Johanna
F
, Mocco
J
, . Emerging technologies in optimizing pre-intervention workflow for acute stroke
. Neurosurgery
. 2019
;85
:S9
–17
.11.
Lumley
HA
, Flynn
D
, Shaw
L
, McClelland
G
, Ford
GA
, White
PM
, . A scoping review of pre-hospital technology to assist ambulance personnel with patient diagnosis or stratification during the emergency assessment of suspected stroke
. BMC Emerg Med
. 2020
;20
(1
):30
.12.
Ziegler
V
, Rashid
A
, Müller-Gorchs
M
, Kippnich
U
, Hiermann
E
, Kögerl
C
, . Mobile computing systems in preclinical care of stroke. Results of the Stroke Angel initiative within the BMBF project PerCoMed
. Anaesthesist
. 2008
;57
(7
):677
–85
.13.
Ziegler
V
, Rashid
A
, Schaff
M
, Kippinch
U
, Griewing
B
. Quality management in acute stroke care: how to evaluate and improve the preclinical/clinical interface in stroke
. Notarzt
. 2012
;28
(6
):237
–45
.14.
Soda
H
, Ziegler
V
, Shammas
L
, Griewing
B
, Kippinch
U
, Keidel
M
, . Telemedical prenotification in acute stroke treatment: experiences from the Stroke Angel initiative from 2004 until the present
. Nervenarzt
. 2017
;88
(2
):120
–9
.15.
Pihlasviita
S
, Mattila
OS
, Ritvonen
J
, Sibolt
G
, Curtze
S
, Strbian
D
, . Diagnosing cerebral ischemia with door-to-thrombolysis times below 20 minutes
. Neurology
. 2018
;91
(6
):e498
–508
.16.
Emberson
J
, Lees
KR
, Lyden
P
, Blackwell
L
, Albers
G
, Bluhmki
E
, . Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
. Lancet
. 2014
;384
(9958
):1929
–35
.17.
Andrew
BY
, Stack
CM
, Yang
JP
, Dodds
JA
. mStroke: “mobile stroke”: improving acute stroke care with smartphone technology
. J Stroke Cerebrovasc Dis
. 2017
;26
(7
):1449
–56
.18.
Meretoja
A
, Strbian
D
, Mustanoja
S
, Tatlisumak
T
, Lindsberg
PJ
, Kaste
M
. Reducing in-hospital delay to 20 minutes in stroke thrombolysis
. Neurology
. 2012
;79
(4
):306
–13
.19.
Bergrath
S
, Reich
A
, Rossaint
R
, Rörtgen
D
, Gerber
J
, Fischermann
H
, . Feasibility of prehospital teleconsultation in acute stroke–a pilot study in clinical routine
. PLoS One
. 2012
;7
(5
):e36796
.20.
Prabhakaran
S
, Lee
J
, O’Neill
K
. Regional learning collaboratives produce rapid and sustainable improvements in stroke thrombolysis times
. Circ Cardiovasc Qual Outcomes
. 2016
;9
(5
):585
–92
.21.
Fayad
P
, Grotta
JC
. Evolving role of mobile stroke units within the prehospital stroke systems of care
. Stroke
. 2020 Jun 1
;51
(6
):1637
–8
.22.
Lippman
JM
, Smith
SN
, McMurry
TL
, Sutton
ZG
, Gunnell
BS
, Cote
J
, . Mobile telestroke during ambulance transport is feasible in a rural EMS setting: the iTREAT study
. Telemed J E Health
. 2016
;22
(6
):507
–13
.23.
Walter
S
, Kostopoulos
P
, Haass
A
, Lesmeister
M
, Grasu
M
, Grunwald
I
, . Point-of-care laboratory halves door-to-therapy-decision time in acute stroke
. Ann Neurol
. 2011
;69
(3
):581
–6
.24.
Xian
Y
, Xu
H
, Lytle
B
, Blevins
J
, Peterson
ED
, Hernandez
AF
, . Use of strategies to improve door-to-needle times with tissue-type plasminogen activator in acute ischemic stroke in clinical practice: findings from target: stroke
. Circ Cardiovasc Qual Outcomes
. 2017
;10
(1
):e003227
.http://dx.doi.org/10.1161/CIRCOUTCOMES.116.003227.10© 2021 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2021
You do not currently have access to this content.
